Search

Displaying 11–20 of 1103 results

• 

  Annual Indianapolis VisionWalk

  • Sep 13, 2025
  • 9:00 a.m. (CDT)
  • 801 W Washington St, Indianapolis, IN 46204

  VisionWalk is a community-driven 5K walk that raises funds and awareness to support the Foundation Fighting Blindness in its mission to cure blinding retinal diseases.

  VisionWalk
• 

  Washington Vision Connection – Fall, 2025

  • Aug 17, 2025
  • 2:00 p.m. (PDT)
  • W Galer St, Seattle, WA 98199

  We invite you to Vision Connection, a new program designed to provide an enriching and supportive environment for the blind and low-vision community.

  Community Event
• 

  St. Louis Vision Connection

  • Aug 5, 2025
  • 5:00 p.m. (CDT)
  • 105 E Jefferson Ave, Kirkwood , MO 63122

  Join the Foundation Fighting Blindness for Vision Connection, an enriching and supportive gathering for the blind and low vision community.

  Community Event
• 

  Colorado Vision Connection – Fall, 2025

  • Aug 2, 2025
  • 11:00 a.m. (PDT)
  • 2550 Roslyn St., Denver, CO 80238

  Learn about adaptive sports and activities at Vision Connection!

  Community Event
• 

  Los Angeles Vision Connection

  • Jul 26, 2025
  • 11:00 a.m. - 2:00 p.m. (PDT)
  • 13479 Glenoaks Blvd, Sylmar, CA 91342

  Join us for a judo presentation from Priscilla Gagne, a judo Paralympic silver medalist!

  Community Event
• 

  Microsoft Scramble for Sight Golf Tournament presented by RE/MAX

  • Jul 22, 2025
  • 9:00 a.m. (MST)
  • 7549 N Daniels Park Rd., Sedalia, CO 80135

  Please join Microsoft and the Foundation Fighting Blindness and help fund valuable research to find a cure for blinding diseases.

  Community Event
• 

  Arizona Chapter July Networking Meeting

  • Jul 19, 2025
  • 5:00 p.m. (PDT)
  • 3609 N Canary Circle, Avondale, AZ 85392

  Summer Pool Party hosted by Lorain and Ron!

  Community Event
• 

  CRB1 Gene Webinar

  • Jul 12, 2025
  • 11:00 a.m. (EDT)
  • Virtual

  CRB1 Program Project Award Kickoff Webinar

  Foundation Event
• 

  Jul 11, 2025

  Eye on the Cure Podcast | Episode 88: Richard Small

  Richard Small, CEO of Neurotech, talks to host Ben Shaberman about ENCELTO™, the first and only FDA-approved treatment for adults with idiopathic Macular Telangiectasia Type 2 (MacTel).

  Eye on the Cure
• 

  Jul 9, 2025

  Atsena Gets FDA Nod to Expand XLRS Gene Therapy Clinical Trial to Include Pivotal Phase 3 Cohort

  The expanded Phase 1/2/3 shortens time to potential FDA approval.

  Research News